Showing results (341-350 of 1,648) with videos related to

Sort By:
Pageof 165
Hepatology International|February 14, 2026
Risk factors of adult recipient survival beyond 20 years since liver transplantation: retrospective cohort studyCarlos Jiménez-Romero, Alfredo Vivas-Lopez, Alberto Marcacuzco, et al.
Hepatology International|March 29, 2025
Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targetsWeixiong Zhu, Chuanlei Fan, Yongqing Zhao, et al.
Hepatology International|April 3, 2025
Model of baseline clinicopathological features predicts non-resolution of drug-induced liver injury at 6 monthsChhagan Bihari, Shvetank Sharma, Apoorva Giri, et al.
Hepatology International|April 3, 2025
Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysisWarunee Mingpun, Agnieszka Sobanska, Mantiwee Nimworapan, et al.
Hepatology International|June 5, 2023
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failureAnand V Kulkarni, Raghuram Reddy, Mithun Sharma, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
Hepatology International|March 10, 2026
mRNA vaccines for hepatocellular carcinoma: mechanisms, therapeutic strategies, and clinical perspectivesZixin Teng, Xiaobing Cui, Chengwei He
Hepatology International|March 18, 2026
A combined model of HBcrAg, anti-HBc, and anti-HBs predicts recurrence after functional cure of chronic hepatitis BXiao Lin, Shan Ren, Chunyang Huang, et al.
Hepatology International|February 20, 2024
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis BMin Zhang, Jing Li, Zhiqiang Xu, et al.
Hepatology International|February 20, 2024
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in TaiwanChao-Wei Hsu, Shin-Cheh Chen, Po-Nan Wang, et al.
Pageof 165